Influenza Vaccine Market to grow by USD 2.93 billion from 2022 to 2027; North America to account for 54% of market growth

/PRNewswire/ -- The influenza vaccine market is expected to grow by USD 2.93 billion from 2022 to 2027. In addition, the momentum of the market will progress...

Related Keywords

United States ,United Kingdom ,America ,Jesse Maida ,Prnewswire Theinfluenza ,Otsuka Holdings Co ,Company Profile ,Mitsubishi Chemical Group Corp ,Biodiem Ltd ,Novavax Inc ,F Hoffmann La Roche Ltd ,Vaccitech Plc ,Pfizer Inc ,Emergent Biosolutions Inc ,Technavio Research ,National Influenza Vaccination Week ,Shijiazhuang Yiling Pharmaceutical Co Ltd ,Company Landscape ,Pan American Health Organization ,Company Analysis ,Sk Chemicals Co ,Vaxart Inc ,Baxter International Inc ,Vaxine Pty Ltd ,Biondvax Pharmaceuticals Ltd ,Altimmune Inc ,Glaxosmithkline Plc ,Flugen Inc ,North America ,Otsuka Holdings ,Vaxine Pty ,Vaccine Market ,Human Vaccine Market ,Technavio ,